Länder Analysen: Schweiz

05.12.23 Roche Underweight JP Morgan Chase & Co.
01.12.23 Roche Sell Deutsche Bank AG
01.12.23 Swiss Re Sell UBS AG
30.11.23 Roche Underweight JP Morgan Chase & Co.
29.11.23 Novartis Underweight Barclays Capital
28.11.23 Givaudan Underperform Bernstein Research
20.11.23 Givaudan Sell UBS AG
14.11.23 DocMorris Sell UBS AG
14.11.23 Swiss Re Sell UBS AG
09.11.23 Zurich Insurance Underweight JP Morgan Chase & Co.
07.11.23 UBS Underweight Barclays Capital
06.11.23 Swiss Re Sell UBS AG
03.11.23 Swiss Re Sell UBS AG
01.11.23 Roche Sell Deutsche Bank AG
31.10.23 Roche Underweight JP Morgan Chase & Co.
30.10.23 Givaudan Sell UBS AG
23.10.23 Novartis Underweight Barclays Capital
23.10.23 Roche Underweight JP Morgan Chase & Co.
20.10.23 DocMorris Sell UBS AG
20.10.23 Roche Sell Deutsche Bank AG
19.10.23 Roche Underweight JP Morgan Chase & Co.
19.10.23 DocMorris Sell UBS AG
19.10.23 Nestlé Underperform RBC Capital Markets
18.10.23 Givaudan Sell UBS AG
13.10.23 Givaudan Sell UBS AG
12.10.23 UBS Underweight Barclays Capital
09.10.23 Roche Underweight JP Morgan Chase & Co.
29.09.23 Givaudan Sell UBS AG
29.09.23 Roche Underweight JP Morgan Chase & Co.
22.09.23 Zurich Insurance Underweight JP Morgan Chase & Co.
21.09.23 Givaudan Sell UBS AG
12.09.23 Swiss Re Sell UBS AG
12.09.23 Roche Sell Deutsche Bank AG
12.09.23 Roche Underweight JP Morgan Chase & Co.
11.09.23 Givaudan Sell UBS AG
07.09.23 Nestlé Underperform RBC Capital Markets
06.09.23 Givaudan Sell UBS AG
05.09.23 Givaudan Underperform Bernstein Research
01.09.23 Roche Underweight JP Morgan Chase & Co.
01.09.23 Zurich Insurance Underweight JP Morgan Chase & Co.
31.08.23 Givaudan Sell UBS AG
31.08.23 Roche Sell Deutsche Bank AG
24.08.23 Givaudan Sell UBS AG
24.08.23 DocMorris Sell UBS AG
24.08.23 Roche Underweight JP Morgan Chase & Co.
23.08.23 Roche Underweight JP Morgan Chase & Co.
18.08.23 DocMorris Underperform Credit Suisse Group
17.08.23 Givaudan Underperform Bernstein Research
14.08.23 UBS Underweight Barclays Capital
10.08.23 Novartis Underweight Barclays Capital